IONQ Stock Cash Flow Statements $42.97 (+6.76%) last: 2025-06-29 20:00:00 EST
IonQ . Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
IonQ . Quarterly Cash Flow Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cash flows from operating activities: | |||||||||||||||
| net income | -32,252,000 | -201,998,000 | -52,496,000 | -37,561,000 | -39,592,000 | -41,904,000 | -44,811,000 | -43,718,000 | -27,338,000 | -18,647,000 | -23,983,000 | -1,654,000 | -4,227,000 | -74,084,000 | -22,144,298 |
| adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||
| depreciation and amortization | 6,561,000 | 5,504,000 | 4,890,000 | 4,305,000 | 3,955,000 | 3,506,000 | 2,749,000 | 2,329,000 | 1,791,000 | 1,356,000 | 1,531,000 | 1,451,000 | 1,266,000 | 1,005,000 | |
| stock-based compensation | 33,253,000 | 39,271,000 | 24,567,000 | 20,979,000 | 22,061,000 | 31,194,000 | 16,977,000 | 11,304,000 | 10,268,000 | 8,895,000 | 10,005,000 | 5,884,000 | 6,672,000 | 1,819,000 | |
| (gain) loss on change in fair value of warrant liabilities | -38,494,000 | 128,505,000 | 3,868,000 | -6,639,000 | -8,627,000 | ||||||||||
| amortization of premiums and accretion of discounts on available-for-sale securities | -1,409,000 | -1,718,000 | -2,299,000 | -2,485,000 | -2,302,000 | -2,459,000 | -2,694,000 | ||||||||
| other | 825,000 | 902,000 | 2,005,000 | 1,087,000 | 809,000 | 438,000 | 300,000 | 2,306,000 | -1,570,000 | -1,098,000 | 1,580,000 | -1,128,000 | -490,000 | ||
| changes in operating assets and liabilities: | |||||||||||||||
| accounts receivable | 748,000 | -5,732,000 | 3,783,000 | 1,661,000 | 1,897,000 | -9,121,000 | -1,128,000 | 30,000 | 2,044,000 | -375,000 | -334,000 | -939,000 | 138,000 | 3,374,000 | |
| prepaid expenses and other current assets | -12,471,000 | -5,301,000 | -1,558,000 | -3,685,000 | -4,656,000 | -6,868,000 | -4,617,000 | -1,989,000 | -939,000 | -5,170,000 | -5,418,000 | 2,060,000 | 1,516,000 | 160,000 | |
| accounts payable | 3,272,000 | -138,000 | -298,000 | 356,000 | -521,000 | 1,213,000 | 496,000 | -249,000 | 728,000 | -1,932,000 | 1,836,000 | 1,447,000 | -291,000 | 1,954,000 | -654,067 |
| accrued expenses and other current liabilities | 6,123,000 | ||||||||||||||
| unearned revenue | 1,299,000 | 2,480,000 | -5,494,000 | -3,127,000 | 4,389,000 | 7,548,000 | -2,939,000 | 1,266,000 | -3,271,000 | 4,447,000 | -819,000 | 1,322,000 | -1,058,000 | -479,000 | |
| other assets and liabilities | -480,000 | -310,000 | 963,000 | -38,000 | 2,546,000 | 2,021,000 | -182,000 | 214,000 | -188,000 | -89,000 | -47,000 | ||||
| net cash from operating activities | -33,025,000 | -39,428,000 | -19,211,000 | -26,579,000 | -20,465,000 | -26,630,000 | -22,280,000 | -16,086,000 | -13,815,000 | -14,913,000 | -12,856,000 | -8,605,000 | -8,324,000 | -4,686,000 | -20,156,431 |
| capex | -3,190,000 | -4,434,000 | -4,705,000 | -8,218,000 | -4,540,000 | -8,583,000 | -5,317,000 | -2,333,000 | -2,028,000 | -1,643,000 | -1,868,000 | -4,875,000 | -3,129,000 | -2,899,000 | 0 |
| free cash flows | -36,215,000 | -43,862,000 | -23,916,000 | -34,797,000 | -25,005,000 | -35,213,000 | -27,597,000 | -18,419,000 | -15,843,000 | -16,556,000 | -14,724,000 | -13,480,000 | -11,453,000 | -7,585,000 | -20,156,431 |
| cash flows from investing activities: | |||||||||||||||
| purchases of property and equipment | -2,308,000 | -3,593,000 | -3,770,000 | -7,489,000 | -3,140,000 | -7,159,000 | -4,133,000 | -1,226,000 | -1,185,000 | -955,000 | -1,359,000 | -4,350,000 | -2,672,000 | -2,483,000 | |
| capitalized software development costs | -882,000 | -841,000 | -935,000 | -729,000 | -1,400,000 | -1,424,000 | -1,184,000 | -1,107,000 | -843,000 | -688,000 | -509,000 | -525,000 | -457,000 | -416,000 | |
| intangible asset acquisition costs | -220,000 | -471,000 | -309,000 | -535,000 | -357,000 | -231,000 | -429,000 | -310,000 | -318,000 | -451,000 | -228,000 | -236,000 | -134,000 | -206,000 | |
| purchases of available-for-sale securities | -320,571,000 | -55,167,000 | -95,064,000 | -79,479,000 | -66,619,000 | -68,095,000 | -44,973,000 | -120,947,000 | -64,430,000 | -116,802,000 | -84,988,000 | -92,664,000 | -311,235,000 | ||
| maturities of available-for-sale securities | 93,805,000 | 99,890,000 | 106,620,000 | 10,400,000 | |||||||||||
| net cash from investing activities | -230,176,000 | 24,364,000 | 6,542,000 | 8,295,000 | 43,529,000 | 24,186,000 | 45,500,000 | -22,235,000 | 21,315,000 | 5,151,000 | 24,976,000 | -35,085,000 | -304,098,000 | -206,871,000 | |
| cash flows from financing activities: | |||||||||||||||
| proceeds from at-the-market offering, net of issuance costs | 362,303,000 | ||||||||||||||
| proceeds from stock options exercised | 1,213,000 | 5,742,000 | 1,085,000 | 699,000 | 486,000 | 1,179,000 | 234,000 | 489,000 | 52,000 | 106,000 | 386,000 | 435,000 | 132,000 | 33,000 | |
| proceeds from public warrants exercised | 4,702,000 | 0 | 1,000 | 0 | 16,000 | ||||||||||
| tax withholding receipts (payments) related to vested and released rsus | 516,000 | 873,000 | |||||||||||||
| net cash from financing activities | 368,734,000 | 39,273,000 | 1,088,000 | -33,000 | 1,359,000 | 977,000 | 244,000 | 506,000 | 34,000 | -1,069,000 | 1,110,000 | 907,000 | 148,000 | 23,288,000 | 579,814,000 |
| effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | -13,000 | 21,000 | 0 | 0 | 4,000 | -5,000 | |||||||||
| net change in cash, cash equivalents and restricted cash | 105,520,000 | 24,230,000 | -11,581,000 | -18,317,000 | 24,427,000 | -1,472,000 | 23,467,000 | -37,815,000 | 7,534,000 | ||||||
| cash, cash equivalents and restricted cash at the beginning of the period | 56,840,000 | 0 | 0 | 0 | 38,081,000 | 0 | 0 | 0 | 46,367,000 | ||||||
| cash, cash equivalents and restricted cash at the end of the period | 162,360,000 | 24,230,000 | -11,581,000 | -18,317,000 | 62,508,000 | -1,472,000 | 23,467,000 | -37,815,000 | 53,901,000 | ||||||
| supplemental disclosures of non-cash investing and financing transactions | |||||||||||||||
| property and equipment purchases in accounts payable and accrued expenses | 152,000 | 501,000 | -1,255,000 | -1,229,000 | 3,043,000 | -3,429,000 | 2,675,000 | 1,374,000 | 153,000 | 299,000 | -1,098,000 | 277,000 | 1,007,000 | 244,000 | |
| intangible asset purchases in accounts payable and accrued expenses | 257,000 | -149,000 | -8,000 | -157,000 | 391,000 | -67,000 | 78,000 | 27,000 | 216,000 | -92,000 | 183,000 | -13,000 | 86,000 | -46,000 | |
| operating lease right-of-use assets subject to lease liability | 0 | 167,000 | 941,000 | 5,021,000 | 0 | 141,000 | 0 | 2,239,000 | |||||||
| noncash reclassification of warrant liabilities to equity upon exercise | 10,953,000 | 13,000 | 0 | 0 | 0 | 8,000 | |||||||||
| bonus settled in restricted stock units | 6,969,000 | 0 | 0 | 0 | 11,443,000 | 1,282,000 | 141,000 | 0 | 0 | ||||||
| net share settled stock option exercises | 0 | 0 | 0 | 1,016,000 | |||||||||||
| at-the-market offering issuance costs in accounts payable and accured expenses | 4,049,000 | ||||||||||||||
| non-cash research and development arrangements | 130,000 | 130,000 | 130,000 | 130,000 | 130,000 | 130,000 | 130,000 | 130,000 | 130,000 | 130,000 | 130,000 | 130,000 | 130,000 | ||
| businesses acquired | |||||||||||||||
| other financing | 94,000 | 3,000 | -202,000 | 10,000 | 17,000 | -18,000 | |||||||||
| remeasurement of operating lease right-of-use assets due to lease modification | |||||||||||||||
| accrued expenses | 2,728,000 | -1,562,000 | -554,000 | -4,747,000 | 5,799,000 | 1,347,000 | 920,000 | -652,000 | 1,512,000 | -1,087,000 | 1,571,000 | -455,000 | -1,323,776 | ||
| maturities and sales of available-for-sale securities | 115,045,000 | 101,095,000 | 96,219,000 | 101,355,000 | 88,091,000 | 124,895,000 | 112,060,000 | ||||||||
| business acquired | |||||||||||||||
| change in fair value of warrant liabilities | 7,640,000 | 15,537,000 | 3,610,000 | -1,778,000 | 1,151,000 | -16,061,000 | -13,448,000 | ||||||||
| supplemental disclosures of non-cash investing and financing transactions: | |||||||||||||||
| amortization of customer warrant | 309,000 | ||||||||||||||
| offering costs associated with warrants | 0 | ||||||||||||||
| tax withholding receipts related to vested and released restricted stock units | |||||||||||||||
| tax withholding payments related to vested and released restricted stock units | |||||||||||||||
| repurchase of early exercised stock options | 0 | ||||||||||||||
| proceeds from merger and pipe transactions, net of transaction costs | |||||||||||||||
| issuance of common stock for intellectual property | 0 | ||||||||||||||
| issuance of common stock for research and development arrangement | 0 | ||||||||||||||
| tax withholding receipts related to vested and released rsus | |||||||||||||||
| tax withholding payments related to vested and released rsus | |||||||||||||||
| net change in cash and cash equivalents | 13,230,000 | -42,783,000 | -312,274,000 | -188,269,000 | |||||||||||
| cash and cash equivalents at the beginning of the period | 0 | 0 | 399,025,000 | 0 | |||||||||||
| cash and cash equivalents at the end of the period | 13,230,000 | -42,783,000 | 86,751,000 | -188,269,000 | |||||||||||
| supplemental disclosure of non-cash investing and financing transactions: | |||||||||||||||
| transaction costs in accounts payable and accrued expenses | |||||||||||||||
| other noncurrent assets | -69,000 | -1,639,000 | |||||||||||||
| operating lease liabilities | -34,000 | -29,000 | |||||||||||||
| proceeds from merger and pipe transaction, net of transaction costs | -2,815,000 | ||||||||||||||
| supplemental disclosures of non-cash investing and financing activities | |||||||||||||||
| vesting of customer warrants | |||||||||||||||
| non-cash operating lease expense | |||||||||||||||
| proceeds from disposal of assets | |||||||||||||||
| vesting of warrants | |||||||||||||||
| change in fair value of derivative warrant liabilities | |||||||||||||||
| gain on marketable securities (net), dividends and interest, held in trust account | |||||||||||||||
| prepaid expenses | |||||||||||||||
| franchise tax payable | |||||||||||||||
| proceeds from advances from related party | |||||||||||||||
| net decrease in cash | |||||||||||||||
| cash - beginning of the period | |||||||||||||||
| cash - end of the period | |||||||||||||||
| supplemental disclosure of noncash activities: | |||||||||||||||
| change value of class a common stock subject to possible redemption | |||||||||||||||
| • |
We provide you with 20 years of cash flow statements for IonQ . stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of IonQ . stock. Explore the full financial landscape of IonQ . stock with our expertly curated income statements.
The information provided in this report about IonQ . stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.